JP Morgan Cazenove Analyst Recommendations & Stock Picks This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at JP Morgan Cazenove. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by JP Morgan Cazenove. Country All Countries United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrial Products Medical Miscellaneous Multi-Sector Conglomerates Oils/Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.Available with a MarketBeat All Access SubscriptionMarketRank™Upgrade to All Access to use the All Ranks Filter Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.Available with a MarketBeat All Access SubscriptionMedia SentimentUpgrade to All Access to use the All Sentiments Filter Analyst consensus is the average investment recommendation among Wall Street research analysts.Available with a MarketBeat All Access SubscriptionAnalyst ConsensusUpgrade to All Access to use the All Ratings Filter Export to Excel CompanyCurrent PriceRating DateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActionsLPSNLivePerson$0.89+4.6%2/25/2022Downgraded byJP Morgan Cazenove-Overweight -> Neutral$60.00 -> $21.00HighView details for JP Morgan Cazenove rating of LivePerson (NASDAQ:LPSN) on 2/25/2022KBCSYKBC Group$38.50+0.7%10/6/2021Target Raised byJP Morgan CazenoveAnalyst Raul SinhaOverweight$79.00 -> $85.00LowView details for JP Morgan Cazenove rating of KBC Group (OTCMKTS:KBCSY) on 10/6/2021IPGInterpublic Group of Companies$28.55+0.7%10/5/2021Target Raised byJP Morgan CazenoveAnalyst Alexia QuadraniOverweight$38.00 -> $43.00MediumView details for JP Morgan Cazenove rating of Interpublic Group of Companies (NYSE:IPG) on 10/5/2021NFLXNetflix$924.14-0.9%9/8/2021Target Raised byJP Morgan CazenoveAnalyst Doug AnmuthOverweight$625.00 -> $705.00LowView details for JP Morgan Cazenove rating of Netflix (NASDAQ:NFLX) on 9/8/2021SCGLYSociété Générale Société anonyme$5.66+0.4%6/16/2021Upgraded byJP Morgan CazenoveAnalyst Kian AbouhosseinOverweightLowView details for JP Morgan Cazenove rating of Société Générale Société anonyme (OTCMKTS:SCGLY) on 6/16/2021BCSBarclays$13.43-0.1%6/16/2021Upgraded byJP Morgan CazenoveAnalyst Kian AbouhosseinOverweightLowView details for JP Morgan Cazenove rating of Barclays (NYSE:BCS) on 6/16/2021NYTNew York Times$53.58+0.4%4/30/2018Reiterated byJP Morgan Cazenove-OverweightHighView details for JP Morgan Cazenove rating of New York Times (NYSE:NYT) on 4/30/2018IRWDIronwood Pharmaceuticals$4.59-0.4%4/28/2016Reiterated byJP Morgan Cazenove-Overweight$15.00N/AView details for JP Morgan Cazenove rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 4/28/2016SANBanco Santander$4.494/25/2016Upgraded byJP Morgan Cazenove-Neutral -> OverweightN/AView details for JP Morgan Cazenove rating of Banco Santander (NYSE:SAN) on 4/25/2016JPMJPMorgan Chase & Co.$243.14+0.3%2/24/2016Target Lowered byJP Morgan Cazenove-Outperform -> Buy$71.00 -> $67.00N/AView details for JP Morgan Cazenove rating of JPMorgan Chase & Co. (NYSE:JPM) on 2/24/2016JPMJPMorgan Chase & Co.$243.14+0.3%2/5/2016Downgraded byJP Morgan Cazenove-Buy -> NeutralN/AView details for JP Morgan Cazenove rating of JPMorgan Chase & Co. (NYSE:JPM) on 2/5/2016AMAntero Midstream$15.15-1.0%2/5/2016Reiterated byJP Morgan Cazenove-Underweight$19.00 -> $25.00N/AView details for JP Morgan Cazenove rating of Antero Midstream (NYSE:AM) on 2/5/2016TROWT. Rowe Price Group$117.58+0.4%1/15/2016Reiterated byJP Morgan Cazenove-Underweight$74.00 -> $68.00N/AView details for JP Morgan Cazenove rating of T. Rowe Price Group (NASDAQ:TROW) on 1/15/2016LYGLloyds Banking Group$2.75+1.1%12/3/2015Reiterated byJP Morgan Cazenove-BuyN/AView details for JP Morgan Cazenove rating of Lloyds Banking Group (NYSE:LYG) on 12/3/2015BCSBarclays$13.43-0.1%11/25/2015Reiterated byJP Morgan Cazenove-BuyN/AView details for JP Morgan Cazenove rating of Barclays (NYSE:BCS) on 11/25/2015GSKGSKGBX 1,341.50+0.6%11/17/2015Reiterated byJP Morgan Cazenove-NeutralGBX 1,370N/AView details for JP Morgan Cazenove rating of GSK (LON:GSK) on 11/17/2015 MarketBeat Community Rating for JP Morgan CazenoveCommunity Ranking: 2.6 out of 5 (2.6 of 5 stars)Outperform Votes: 34,233 (Vote Outperform)Underperform Votes: 30,976 (Vote Underperform)Total Votes: 65,209MarketBeat's community ratings are surveys of what our community members think about JP Morgan Cazenove and other research firms. Vote "Outperform" if you believe JP Morgan Cazenove's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe JP Morgan Cazenove's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days. Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
